Last $48.74 USD
Change Today -2.05 / -4.04%
Volume 1.0M
LGND On Other Exchanges
Symbol
Exchange
NASDAQ GM
OTC US
Frankfurt
OTC US
OTC US
OTC US
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John L. Higgins

Chief Executive Officer, President and Executive Director, Ligand Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 31 board members in 3 different organizations across 5 different industries.

See Board Relationships
44$3,004,911
As of Fiscal Year 2013

Background*

Mr. John L. Higgins has been Chief Executive Officer and President of Ligand Pharmaceuticals Inc. of Metabasis Therapeutics Inc. since January 16, 2007. Mr. Higgins serves as the President and Chief Executive Officer of Moonstone Acquisition, Inc. He has over 14 years of corporate development, financing, strategic planning, commercialization and investment banking experience in the Biopharmaceutical Industry. He served as Chief Financial Officer of Connetics Corporation ...

Read Full Background

Corporate Headquarters*

11119 North Torrey Pines Road
La Jolla, California 92037

United States

Phone: 858-550-7500
Fax: --

Board Members Memberships*

2004-2013
Former Director
2007-Present
Chief Executive Officer, President and Executive Director
2008-Present
Director
2009-Present
Director, Member of Audit Committee, Member of Executive Compensation Committee and Member of Nominations & Governance Committee

Education*

BA
Colgate University

Other Affiliations*

Annual Compensation*

Salary$500,331
Total Annual Compensation$500,331

Stock Options*

Restricted Stock Awards$559,360
All Other Compensation$2,843
Exercised Options17,074
Exercised Options Value$382,070
Exercisable Options251,054
Exercisable Options Value$9,879,970
Unexercisable Options214,944
Unexercisable Options Value$7,583,777
Total Value of Options$17,845,817
Total Number of Options483,072

Total Compensation*

Total Annual Cash Compensation$878,422
Total Short Term Compensation$500,331
Other Long Term Compensation$562,203
Total Calculated Compensation$3,004,911
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LGND:US $48.74 USD -2.05

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIGAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.